fda announcement semaglutide π’ has determined the shortage of injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the As of February 21, 2025,
Description
A licensed provider should walk through the trade-offs before either pathway starts
As semaglutide lingers in the body for a long period, it should be stopped well ahead of a planned pregnancy
Reconstitution: 3.0 mL per 30 mg vial (~10.0 mg/mL) for accurate unit measurements
But long-term, stress might increase your cravings and promote fat storage
